Skip to main content

Periodontitis and Atherosclerosis, a Causal Relationship?

Buy Article:

$68.00 + tax (Refund Policy)

Periodontal and atheromatous diseases affect a large proportion of the general population. They have been associated with each other and may be causally linked. It has not proved possible to confirm a causal relationship between periodontitis and atherosclerosis to date and contradictory results have been published, likely due to the multi-factorial nature of these diseases. The Medline database (PubMed) was explored for papers published in English, using a wide search strategy. This review discusses pathophysiological hypotheses on the possible link between atherosclerosis and periodontitis and analyzes the direct effect on the vascular endothelium of periodontopathogens, biochemical markers of chronic inflammation, pro-inflammatory cytokines and the role of atherogenic proteins in periodontitis. The article includes crosssectional, case-control, longitudinal, and interventional studies, and describes the latest meta-analyses published in the literature. Scientific evidence to date indicates that periodontitis is a risk factor for atherosclerosis, but longitudinal studies of large samples are required to determine whether there is a causal relationship between these diseases.





Keywords: Atherosclerosis; chronic inflammation; periodontitis

Document Type: Research Article

Publication date: 01 September 2008

More about this publication?
  • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Anti-Inflammatory & Anti-Allergy Agents.

    Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Anti-Inflammatory & Anti-Allergy Medicinal Chemistry.

    Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Anti-Inflammatory & Anti-Allergy Agents drug discovery.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content